The total human evidence base, as of this writing, consists of the following: 1) a Phase I safety trial of 42 healthy volunteers that was registered in 2015, canceled in 2016, and never published, 2) a retrospective case series of 12 patients with knee pain, no control group, and no validated outcome measure, and 3) a 2025 pilot safety study involving two healthy adults who received intravenous infusions at a single private clinic in Florida
BPC 157 has been shown in rat studies to improve healing of GI fistulas by accelerating the rate of repair and leading to more frequent closure of the fistula
Studies suggest that the BPC-157 TB500 blend peptide therapy may enhance the individual benefits of each peptide, providing a comprehensive approach to recovery and regeneration
Lipotropic Injections Procedure All medications are not suitable for everybody
If youre not already subscribed, join 69,000+ people who receive actionable insights directly in their inbox each week
